2 Top Stocks to Buy in August and Hold Forever
Technological progress sometimes renders products or entire industries completely obsolete. That's true even within the healthcare sector, which as a whole is unlikely to fall out of style anytime soon. Even so, individual healthcare companies must constantly innovate to stay relevant and deliver consistent performances over the long run.
With that said, let's look at two healthcare stocks with solid track records of innovation and are worth buying and holding onto for good: Regeneron (NASDAQ: REGN) and Abbott Laboratories (NYSE: ABT).
Source Fool.com
Regeneron Pharmaceuticals Inc. Aktie
1.021,0 €
-1,50 %
Die Regeneron Pharmaceuticals Inc. Aktie zieht viel Aufmerksamkeit auf sich: Viel mehr Buy- als Sell-Einschätzungen.
Ein Kursziel von 1085 € für Regeneron Pharmaceuticals Inc. zeigt ein leicht positives Potenzial im Vergleich zum aktuellen Kurs von 1021.0 €.
